INmune Bio

+$0.16 (+2.59%) Today
$0.00 (0.00%) As of 8:00 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell INmune Bio and other ETFs, options, and stocks.

About INMB

INmune Bio, Inc. Is a clinical stage biotechnology company, which engages in developing new immunotherapies that reprograms the immune system to fight cancer and Alzheimer’s disease.

CEO
Raymond J. Tesi
Employees
10
Headquarters
Boca Raton, Florida
Founded
2015

INMB Key Statistics

Market cap
113.60M
Price-Earnings ratio
—
Dividend yield
—
Average volume
227.78K
High today
$6.43
Low today
$6.05
Open price
$6.09
Volume
204.49K
52 Week high
$30.37
52 Week low
$4.63

INMB News

MarketWatchMay 24

INmune Bio stock plunges after clinical hold of IND of Alzheimer's treatment prompts analyst downgrade

Shares of INmune Bio Inc. INMB, -1.09% plummeted 31.4% toward a 22-month low in premarket trading Tuesday, after the Florida-based biotechnology company said it

INMB Earnings

-$0.64
-$0.43
-$0.21
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 3, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure